Screener
Kestra Medical Technologies KMTS Ratios & Valuation
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 53.9%+10.4pp | 51.4%+10.9pp | 48.8%+15.1pp | 46.4%+21.7pp | 43.5%+30.2pp | |
| Operating margin | -134.5%+41.5pp | -141.6%+36.2pp | -171.5%-11.2pp | -174.3%+19.2pp | -175.9%+68.5pp | |
| Net margin | -140.4%+39.9pp | -138.4%+51.9pp | -173%-0.8pp | -178%+32.9pp | -180.3%+88.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×— | 0.3×-0.1× | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 4.7×-2.2× | 4.4×-2.3× | 7.3×— | 5.5×— | 6.8×— | |
| Valuation | ||||||
| Market capitalization | $1.62B+28.9% | $1.21B— | $1.44B— | $1.41B— | $847.25M— | |
| Price / sales | 15.1×-3.7× | 12.7×— | 17.2×— | 19×— | 12.8×— |
FAQ
- What are Kestra Medical Technologies's profit margins?
- Kestra Medical Technologies (KMTS) runs a 53.9% gross margin and a -134.5% operating margin, with a -140.4% net margin.
- Where do Kestra Medical Technologies's ratios come from?
- Every ratio is computed from Kestra Medical Technologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
